CORRECTION OF ANAEMIA WITH ERYTHROPOIETIN IN CKD/ESRD PATIENTS
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2015, Vol 4, Issue 12
Abstract
Chronic kidney disease (CKD) is characterized by gradual and permanent loss of kidney function. One of the most common complications of CKD is Anaemia.1,3 Anaemia often appears earlier in course of CKD and worsens with disease progression.1,2 Erythropoietin is a hormone synthesized in the kidney is deficient in the majority of patients of CKD thereby predisposing them for developing anaemia. Erythropoiesis stimulating agents ESAs) first became clinically available in 1989 and has contributed to the advances in the management of CKD related anemia. The present study highlights the correction of anaemia with erythropoietin (Eprex) in population having CKD on MHD and anaemia. Based on GFR CKD is divided into five stages from 1-5. Patients often become anaemic at stage 3 or 4 CKD but anaemia may develop as early as stage 2. And it is present in the majority of patients with stage 5 disease.2,4 The objective of this study is to evaluate efficacy of administration of 10000.U. Epotin alfa sc for once a week as initiation therapy in patients with anaemia of CKD/ESRD on MHD for 28 weeks of duration of treatment. It is a prospective study done at Central Hospital, South Central Railway, Secunderabad on patients with ESRD or stage 4 on maintenance hemodialysis and receiving subcutaneously EPO (Eprex). Serum feritin and %transferrin saturation are estimated before the initiation of EPO(Eprex) & if the levels are below normal, IV IRON 100 mg is given once weekly and oral elemental Iron 200 to 400 mg to every to normalize the serum ferritin and % transferrin saturation levels. Hemoglobin level estimation has done before and after the initiation of the EPO (Eprex) and once in weekly and four weekly to see the response more than 1gm in four weeks to achieve the target hemoglobin level (11 to 12 grams) in 28 weeks. In the present study target hemoglobin level (11-12g/dl) was achieved in 42 out of 50 patients under consideration (84%) in 28 weeks of duration of treatment and not achieved for 8 amongst 50(16%) patients. Increase in the hemoglobin level of 1/dl is seen in 13(26%),>1 g/dl in 29(58%) and <1 g/dl in 8(16%) patients.
Authors and Affiliations
Madhukar Gaikwad, Shyamal Sinha, Rashmi Sinha, Anitha Gore, Bhattacharjee S, Anjaiah T, Abdul Hannan, Kunal Patankar
Keywords
Related Articles
- EP ID EP106419
- DOI 10.14260/jemds/2015/280
- Views 128
- Downloads 0
A STUDY ON THE PREVALENCE OF ASYMPTOMATIC BACTERIURIA AND THEIR ANTIBIOGRAM PATTERN AMONG PREGNANT WOMEN IN A TERTIARY CARE HOSPITAL
[b] BACKGROUND:[/b] Asymptomatic bacteriuria (ASB) is common in pregnancy, if left untreated it may lead to adverse maternal and fetal complications like abortion, premature delivery and low birth weight. Early...
CLINICOPATHOLOGICAL STUDY OF NEOPLASM’S OF TESTIS IN A TERTIARY CARE HOSPITAL
Testicular tumor mainly affects young men. Considerable therapeutic improvements in management based on the cancer's responsiveness to chemotherapy that contains platinum meansthat over 95% of these patients can be c...
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE WITH CONGENITAL HEPATIC FIBROSIS- A CASE REPORT
PRESENTATION OF CASE A 11 years old female child presented with pain abdomen and abdominal distension on and off ever since she was 4 years; not associated with vomiting or altered bowel habits. There was no history of f...
A REVIEW ON THERMOGRAPHY IN DENTISTRY
The study and application of biothermal process to assess health or disease is termed as Thermology and the imaging and visual evaluation of these thermal changes is termed “Thermography.” Over the years, a variety of de...
MEDICAL EXPULSIVE THERAPY- AN EFFECTIVE TREATMENT OPTION FOR LOWER URETERIC CALCULI
BACKGROUND This is a prospective randomized trial to study the efficacy of medical expulsive therapy for lower ureteric calculi. Ureteral stones are a global health issue. Almost 20% of urinary tract stones are found in...